Back

XGEN appoints David Hoffman and Mark Evans as executive and medical directors

Verifying
  • XGEN appointed David Hoffman and Mark Evans to its Board and medical leadership.
  • Panacea-GenomeScreen screens for more than 3,200 diseases at greater than 30x coverage.
  • XGEN PGT-X launched at PGDIS in Shanghai at US$499 per embryo in 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.